To explore the distribution of metastatic disease in pN1 patients with biochemical recurrence (BCR) assessed by Prostate‐Specific Membrane Antigen‐Positron‐Emission/Computed Tomography (PSMA‐PET/CT). The gene discussed is FOLH1; the disease is metastatic neoplasm.